News from grifols A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:GRFS,SpanishCats:GRF,OTC-PINK:GIKLY,SpanishCats:GRF.P)

Jun 17, 2014, 09:00 ET

Grifols opens state-of-the-art facility in Clayton, NC to help advance treatment of rare and life-threatening diseases

 Today, Grifols (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS), a leader in the production of plasma-derived medicines, celebrated the grand opening of...

May 14, 2014, 05:23 ET

Grifols verkündet die Verfügbarkeit des AlphaKit® QuickScreen, eines neuartigen Point-of-Care Screening Tests zur Unterstützung beim Auschluss von Alpha-1-Antitrypsin Mangel (AATM)

- AlphaKit® QuickScreen ist ein neuartiger, immun-chromatographischer, in-vitro diagnostischer Screening Test auf die Z-Form des...

Apr 17, 2014, 08:47 ET

Grifols Celebrates World Hemophilia Day with Donation of Coagulation Medicines to the World Federation of Hemophilia

 Grifols, S.A. (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) today announced that it will donate up to 20 million units of coagulation therapies in...

Apr 04, 2014, 11:54 ET

Annual Report for 2013 on Form 20-F filed with the SEC on April 4, 2014

 Grifols, S.A. ("Grifols") (MCE:GRF, MCE:GRF.P and NASDAQ:GRFS), announced that it has filed its 2013 Annual Report on Form 20-F with the...

Nov 12, 2013, 08:08 ET

Grifols va acquérir les activités diagnostiques de Novartis pour 1 675 millions de dollars

- Les actifs acquis comprennent des produits de diagnostic in vitro et une technologie de médicine et d'immunologie transfusionnelle, une...

Nov 11, 2013, 02:18 ET

Grifols to acquire a Novartis diagnostics business unit for US$1,675 million

- The assets acquired include in vitro diagnostic products and technology for transfusion medicine and immunology, a manufacturing plant...

Oct 04, 2013, 08:45 ET
Grifols Logo.  (PRNewsFoto/Grifols)

Grifols Announces Launch of the SPIRIT Registry at the NHF Annual Meeting

 Grifols Inc., a leading manufacturer of life-saving plasma protein therapies, today announced the launch of the SPIRIT (Study of...

Sep 09, 2013, 17:03 ET
Grifols Logo.  (PRNewsFoto/Grifols)

Grifols verkündet Gewinner des 10. jährlichen Forschungsstipendiums eALTA beim ERS-Kongress 2013

- Die Stipendien finanzieren Forschung aus beginnenden Forschungskarrieren zur Förderung des Verständnisses und der Behandlung des...

Sep 09, 2013, 12:46 ET
Sep 09, 2013, 12:39 ET
Grifols Logo.  (PRNewsFoto/Grifols)

Grifols annuncia i vincitori della decima borsa di ricerca eALTA nel corso del Congresso ERS 2013

- I premi finanziano la ricerca da parte di giovani sperimentatori per una maggiore conoscenza del deficit di alfa1-antitripsina e delle relative...

Sep 09, 2013, 03:00 ET
Aug 12, 2013, 14:11 ET
Grifols Logo.  (PRNewsFoto/Grifols)

California State Legislature recognizes Grifols for its Decennial Anniversary in California

 Today Grifols was honored at the California State Legislature by state Senator Kevin de Leon (D-Los Angeles) and Assembly Member Jimmy...

Jul 18, 2013, 08:47 ET

Grifols implementa il suo primo sistema a carosello per la gestione automatizzata dell'inventario dei farmaci sperimentali presso la Emory University

 Grifols, società mondiale del settore sanitario con sede a Barcellona, Spagna, che vanta oltre 15 anni di innovazione ed esperienza nel...

Jul 18, 2013, 08:47 ET

Grifols implemetiert erstes automatisiertes Karussellsystem für das Bestandmanagement von Prüfpräparaten an der Emory University

 Grifols, ein globales medizinisches Unternehmen mit Sitz in Barcelona, Spanien, und über 15 Jahren an Innovations- und Betriebserfahrung...

Jul 18, 2013, 08:47 ET

Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University

 Grifols, a global healthcare company based in Barcelona, Spain with more than 15 years of innovation and expertise with automated drug storage...

May 22, 2013, 08:47 ET

Lo studio Grifols dimostra che dosi più elevate di PROLASTIN-C aumentano i livelli di alfa1-PI portandoli ai valori normali nei pazienti affetti da deficit di alfa1-antitripsina

- I risultati dello studio presentati alla conferenza annuale della American Thoracic Society (ATS – Società Americana del Torace)...

May 22, 2013, 08:47 ET

Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt

- Die Ergebnisse der Studie wurden auf der Jahrestagung der American Thoracic Society (ATS) präsentiert  Grifols, ein globales...

May 22, 2013, 08:47 ET

Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency

 Grifols, a global healthcare company based in Barcelona, Spain, presented results from a study demonstrating that a higher dose of...

Apr 05, 2013, 12:29 ET

Annual Report for 2012 on Form 20-F filed with the SEC on April 5, 2013

Grifols, S.A. ("Grifols") (MCE:GRF, MCE:GRF.P and NASDAQ: GRFS), announced that it has filed its 2012 Annual Report on Form 20-F with the United...

Feb 07, 2013, 13:20 ET
Grifols Logo.  (PRNewsFoto/Grifols)

PROLASTIN® comemora 25 anos como principal tratamento de reposição para deficiência de alfa(1)-antitripsina

A Grifols, empresa global da área de saúde e sediada em Barcelona, Espanha, está comemorando o 25o aniversário do...